#Haryana #PGIMER #Chandigarh #COVID19 #Coronavirus
Gurugram (Haryana), Apr 29(ANI): CSIR-IIIM Director and coordinator of trial programme for use of Sepsivac in COVID-19 treatment, Dr. Ram Vishwakarma said that Clinical trial has begun at PGIMER Chandigarh to position immunomodulator Sepsivac as a drug.
--------------------------------------
Subscribe now! Enjoy and stay connected with us!!
☛ Subscribe ANI News channel: [ Ссылка ]
☛ Visit our Official website: [ Ссылка ]
☛ Follow ANI News: [ Ссылка ]
☛ Like us: [ Ссылка ]
☛ Email to Shrawan K Poddar: shrawankp@aniin.com
☛ Copyrights © All Rights Reserved ANI Media Pvt Ltd.
